Bangalore, Karnataka -- (SBWIRE) -- 05/18/2016 -- Cirrhosis of the liver (or liver fibrosis) is a serious condition in which the liver stops functioning properly due to damage and irreversible scarring of the liver tissue. The scarring of the tissue is often caused by long-term exposure to viral infections and toxins such as alcohol. Chronic viral hepatitis and non-alcoholic steatohepatitis can also cause liver cirrhosis. Alcohol-related medications, antiviral medications, and metal chelating agents are used in the treatment of the causes of liver cirrhosis while antibiotics, vitamins, corticosteroids, diuretics, beta-blockers, and laxatives are used for the treatment of the complications of the disease.

Report forecast the global liver cirrhosis therapeutics market to grow at a CAGR of 4.36% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global liver cirrhosis therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of liver cirrhosis.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Liver Cirrhosis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- F Hoffman La-Roche
- GlaxoSmithKline
- Gilead Sciences
- Johnson & Johnson
- Merck

Other prominent vendors
- Bristol-Myers Squibb
- Conatus Pharmaceuticals
- Gwo Xi Stem Cell Applied Technology
- Instituto Grifols
- Intercept Pharmaceuticals
- NGM Biopharmaceuticals
- Norgine
- Pharmicell
- Salix Pharmaceuticals
- Stempeutics Research

Market driver
- High prevalence of liver cirrhosis
- For a full, detailed list, view our report

Market challenge
- Adverse effects of drugs
- For a full, detailed list, view our report

Market trend
- Use of off-label drugs
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 74 pages "Global Liver Cirrhosis Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Disease overview, Pipeline portfolio, Market landscape, Market segmentation by type of molecule, Market segmentation by types of liver cirrhosis, Market segmentation by types of liver cirrhosis treatment, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-liver-cirrhosis-market-2016-2020

Related Reports:

Global Non-alcoholic Steatohepatitis Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-non-alcoholic-steatohepatitis-market-2016-2020

Global 3D Medical Imaging Equipment Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-3d-medical-imaging-equipment-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.

Press Contact:
Mr. Sudeep Chakravarty
Director - Operations
http://www.drugpipeline.net/
Tel USA: +1-302-703-7787
Tel India: +91-9538405942